Table 1.
Descriptive statistics with respect to the study groups.
| Gene * | BC Metastasis Status | U-Value | p-Value ** | ES | |
|---|---|---|---|---|---|
| Non-Metastasis | Metastasis | ||||
| ARL4D | 0.401 (1.028) | −0.198 (0.477) | 1093 | <0.001 | 0.143 (medium) |
| TGFB3 | 0.38 (0.994) | −0.248 (0.754) | 1093 | <0.001 | 0.164 (medium) |
| PHF1 | 0.409 (0.916) | −0.221 (0.505) | 788 | <0.001 | 0.173 (medium) |
| PSMD7 | −0.228 (0.67) | 0.458 (0.808) | 887 | <0.001 | 0.188 (medium) |
| CACTIN | 0.248 (0.74) | −0.36 (0.748) | 865 | <0.001 | 0.213 (medium) |
| OR1F1 | 0.404 (1.237) | −0.128 (0.471) | 932.5 | <0.001 | 0.143 (medium) |
| ALDH4A1 | 0.312 (0.713) | −0.412 (0.962) | 982.5 | <0.001 | 0.194 (medium) |
| PRAME | −0.072 (0.226) | 0.744 (1.158) | 1086.5 | <0.001 | 0.135 (medium) |
| UBQLN1 | −0.381 (0.755) | 0.262 (1.06) | 1042 | <0.001 | 0.17 (medium) |
| UBE2T | −0.329 (0.923) | 0.327 (0.635) | 986 | <0.001 | 0.176 (medium) |
| SCUBE2 | 0.245 (0.484) | −0.576 (0.735) | 915 | <0.001 | 0.212 (medium) |
| TSPYL5 | −0.305 (0.599) | 0.51 (0.759) | 961.5 | <0.001 | 0.306 (large) |
| ARIH1 | −0.396 (0.935) | 0.331 (0.792) | 844 | <0.001 | 0.197 (medium) |
| CROCC | 0.455 (0.77) | −0.291 (0.706) | 1022 | <0.001 | 0.191 (medium) |
| ATP5E | −0.401 (0.818) | 0.283 (1.057) | 1013 | <0.001 | 0.196 (medium) |
| NUP210 | −0.094 (0.532) | 0.468 (0.958) | 1075 | 0.001 | 0.117 (medium) |
| CA9 | −0.177 (0.617) | 0.379 (1.171) | 852 | <0.001 | 0.176 (medium) |
| SLC37A1 | −0.121 (0.872) | 0.338 (1.085) | 1051 | 0.002 | 0.0977 (medium) |
*: Gene expression levels are summarized as ‘Median (IQR)’; **: Mann–Whitney U test; ES: effect size; BC: Breast cancer.